nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—UGT1A9—Mycophenolic acid—systemic scleroderma	0.36	0.522	CbGbCtD
Hydromorphone—UGT1A9—Mycophenolate mofetil—systemic scleroderma	0.201	0.292	CbGbCtD
Hydromorphone—CYP2C9—Leflunomide—systemic scleroderma	0.0544	0.0789	CbGbCtD
Hydromorphone—CYP2D6—Captopril—systemic scleroderma	0.039	0.0566	CbGbCtD
Hydromorphone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0195	0.0283	CbGbCtD
Hydromorphone—CYP3A4—Prednisone—systemic scleroderma	0.0156	0.0227	CbGbCtD
Hydromorphone—CYP2C9—cardial valve—systemic scleroderma	0.00755	0.531	CbGeAlD
Hydromorphone—UGT1A9—digestive system—systemic scleroderma	0.00113	0.0798	CbGeAlD
Hydromorphone—PTGS1—artery—systemic scleroderma	0.00103	0.0727	CbGeAlD
Hydromorphone—PTGS1—endothelium—systemic scleroderma	0.000873	0.0615	CbGeAlD
Hydromorphone—PTGS1—blood vessel—systemic scleroderma	0.000805	0.0567	CbGeAlD
Hydromorphone—PTGS1—connective tissue—systemic scleroderma	0.000413	0.0291	CbGeAlD
Hydromorphone—PTGS1—smooth muscle tissue—systemic scleroderma	0.000378	0.0266	CbGeAlD
Hydromorphone—PTGS1—skin of body—systemic scleroderma	0.000373	0.0262	CbGeAlD
Hydromorphone—CYP2C9—digestive system—systemic scleroderma	0.000327	0.023	CbGeAlD
Hydromorphone—PTGS1—digestive system—systemic scleroderma	0.000298	0.021	CbGeAlD
Hydromorphone—PTGS1—tendon—systemic scleroderma	0.000284	0.02	CbGeAlD
Hydromorphone—CYP3A4—digestive system—systemic scleroderma	0.000249	0.0175	CbGeAlD
Hydromorphone—PTGS1—lung—systemic scleroderma	0.000249	0.0175	CbGeAlD
Hydromorphone—CYP2D6—digestive system—systemic scleroderma	0.000245	0.0172	CbGeAlD
Hydromorphone—Fatigue—Mycophenolic acid—systemic scleroderma	0.000181	0.000611	CcSEcCtD
Hydromorphone—Mood swings—Methotrexate—systemic scleroderma	0.000181	0.000611	CcSEcCtD
Hydromorphone—Nausea—Mometasone—systemic scleroderma	0.000181	0.000609	CcSEcCtD
Hydromorphone—Anorexia—Lisinopril—systemic scleroderma	0.00018	0.000608	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00018	0.000607	CcSEcCtD
Hydromorphone—Pain—Mycophenolic acid—systemic scleroderma	0.00018	0.000606	CcSEcCtD
Hydromorphone—Constipation—Mycophenolic acid—systemic scleroderma	0.00018	0.000606	CcSEcCtD
Hydromorphone—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000605	CcSEcCtD
Hydromorphone—Weight decreased—Prednisone—systemic scleroderma	0.000179	0.000603	CcSEcCtD
Hydromorphone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000602	CcSEcCtD
Hydromorphone—Cough—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000598	CcSEcCtD
Hydromorphone—Hypotension—Lisinopril—systemic scleroderma	0.000177	0.000596	CcSEcCtD
Hydromorphone—Dizziness—Captopril—systemic scleroderma	0.000177	0.000596	CcSEcCtD
Hydromorphone—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000594	CcSEcCtD
Hydromorphone—Depression—Prednisone—systemic scleroderma	0.000176	0.000593	CcSEcCtD
Hydromorphone—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000592	CcSEcCtD
Hydromorphone—Urticaria—Leflunomide—systemic scleroderma	0.000175	0.00059	CcSEcCtD
Hydromorphone—Abdominal pain—Leflunomide—systemic scleroderma	0.000174	0.000587	CcSEcCtD
Hydromorphone—Body temperature increased—Leflunomide—systemic scleroderma	0.000174	0.000587	CcSEcCtD
Hydromorphone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000173	0.000584	CcSEcCtD
Hydromorphone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000583	CcSEcCtD
Hydromorphone—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000583	CcSEcCtD
Hydromorphone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000583	CcSEcCtD
Hydromorphone—Breast disorder—Methotrexate—systemic scleroderma	0.000173	0.000582	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000173	0.000581	CcSEcCtD
Hydromorphone—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000581	CcSEcCtD
Hydromorphone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000172	0.000579	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000172	0.000579	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000579	CcSEcCtD
Hydromorphone—Insomnia—Lisinopril—systemic scleroderma	0.000171	0.000577	CcSEcCtD
Hydromorphone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000576	CcSEcCtD
Hydromorphone—Paraesthesia—Lisinopril—systemic scleroderma	0.00017	0.000573	CcSEcCtD
Hydromorphone—Vomiting—Captopril—systemic scleroderma	0.00017	0.000573	CcSEcCtD
Hydromorphone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000169	0.00057	CcSEcCtD
Hydromorphone—Dyspnoea—Lisinopril—systemic scleroderma	0.000169	0.000569	CcSEcCtD
Hydromorphone—Rash—Captopril—systemic scleroderma	0.000169	0.000568	CcSEcCtD
Hydromorphone—Dermatitis—Captopril—systemic scleroderma	0.000168	0.000568	CcSEcCtD
Hydromorphone—Somnolence—Lisinopril—systemic scleroderma	0.000168	0.000567	CcSEcCtD
Hydromorphone—Headache—Captopril—systemic scleroderma	0.000167	0.000565	CcSEcCtD
Hydromorphone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000564	CcSEcCtD
Hydromorphone—Dyspepsia—Lisinopril—systemic scleroderma	0.000167	0.000562	CcSEcCtD
Hydromorphone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000166	0.00056	CcSEcCtD
Hydromorphone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000166	0.00056	CcSEcCtD
Hydromorphone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000559	CcSEcCtD
Hydromorphone—Asthma—Methotrexate—systemic scleroderma	0.000165	0.000557	CcSEcCtD
Hydromorphone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000556	CcSEcCtD
Hydromorphone—Decreased appetite—Lisinopril—systemic scleroderma	0.000165	0.000555	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000163	0.000551	CcSEcCtD
Hydromorphone—Fatigue—Lisinopril—systemic scleroderma	0.000163	0.00055	CcSEcCtD
Hydromorphone—Shock—Mycophenolate mofetil—systemic scleroderma	0.000163	0.00055	CcSEcCtD
Hydromorphone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000548	CcSEcCtD
Hydromorphone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000162	0.000547	CcSEcCtD
Hydromorphone—Pain—Lisinopril—systemic scleroderma	0.000162	0.000546	CcSEcCtD
Hydromorphone—Constipation—Lisinopril—systemic scleroderma	0.000162	0.000546	CcSEcCtD
Hydromorphone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000546	CcSEcCtD
Hydromorphone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000543	CcSEcCtD
Hydromorphone—Bradycardia—Prednisone—systemic scleroderma	0.000161	0.000543	CcSEcCtD
Hydromorphone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000541	CcSEcCtD
Hydromorphone—Diarrhoea—Azathioprine—systemic scleroderma	0.00016	0.000538	CcSEcCtD
Hydromorphone—Nausea—Captopril—systemic scleroderma	0.000159	0.000535	CcSEcCtD
Hydromorphone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000533	CcSEcCtD
Hydromorphone—Asthenia—Leflunomide—systemic scleroderma	0.000158	0.000533	CcSEcCtD
Hydromorphone—Hallucination—Prednisone—systemic scleroderma	0.000157	0.000531	CcSEcCtD
Hydromorphone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000156	0.000526	CcSEcCtD
Hydromorphone—Pruritus—Leflunomide—systemic scleroderma	0.000156	0.000525	CcSEcCtD
Hydromorphone—Connective tissue disorder—Prednisone—systemic scleroderma	0.000156	0.000524	CcSEcCtD
Hydromorphone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000523	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000155	0.000522	CcSEcCtD
Hydromorphone—Dysuria—Methotrexate—systemic scleroderma	0.000155	0.000521	CcSEcCtD
Hydromorphone—Dizziness—Azathioprine—systemic scleroderma	0.000154	0.00052	CcSEcCtD
Hydromorphone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000152	0.000513	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000509	CcSEcCtD
Hydromorphone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000151	0.000508	CcSEcCtD
Hydromorphone—Diarrhoea—Leflunomide—systemic scleroderma	0.000151	0.000508	CcSEcCtD
Hydromorphone—Urticaria—Lisinopril—systemic scleroderma	0.00015	0.000507	CcSEcCtD
Hydromorphone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000506	CcSEcCtD
Hydromorphone—Abdominal pain—Lisinopril—systemic scleroderma	0.00015	0.000505	CcSEcCtD
Hydromorphone—Body temperature increased—Lisinopril—systemic scleroderma	0.00015	0.000505	CcSEcCtD
Hydromorphone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000502	CcSEcCtD
Hydromorphone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000149	0.000501	CcSEcCtD
Hydromorphone—Vomiting—Azathioprine—systemic scleroderma	0.000148	0.0005	CcSEcCtD
Hydromorphone—Eye disorder—Prednisone—systemic scleroderma	0.000148	0.000499	CcSEcCtD
Hydromorphone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000499	CcSEcCtD
Hydromorphone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000497	CcSEcCtD
Hydromorphone—Infestation—Methotrexate—systemic scleroderma	0.000147	0.000497	CcSEcCtD
Hydromorphone—Infestation NOS—Methotrexate—systemic scleroderma	0.000147	0.000497	CcSEcCtD
Hydromorphone—Drowsiness—Methotrexate—systemic scleroderma	0.000147	0.000497	CcSEcCtD
Hydromorphone—Rash—Azathioprine—systemic scleroderma	0.000147	0.000496	CcSEcCtD
Hydromorphone—Dermatitis—Azathioprine—systemic scleroderma	0.000147	0.000495	CcSEcCtD
Hydromorphone—Depression—Methotrexate—systemic scleroderma	0.000147	0.000495	CcSEcCtD
Hydromorphone—Flushing—Prednisone—systemic scleroderma	0.000147	0.000495	CcSEcCtD
Hydromorphone—Headache—Azathioprine—systemic scleroderma	0.000146	0.000493	CcSEcCtD
Hydromorphone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000492	CcSEcCtD
Hydromorphone—Dizziness—Leflunomide—systemic scleroderma	0.000146	0.000491	CcSEcCtD
Hydromorphone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000486	CcSEcCtD
Hydromorphone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000144	0.000485	CcSEcCtD
Hydromorphone—Stomatitis—Methotrexate—systemic scleroderma	0.000144	0.000484	CcSEcCtD
Hydromorphone—Angiopathy—Prednisone—systemic scleroderma	0.000144	0.000484	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000483	CcSEcCtD
Hydromorphone—Immune system disorder—Prednisone—systemic scleroderma	0.000143	0.000482	CcSEcCtD
Hydromorphone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000478	CcSEcCtD
Hydromorphone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000478	CcSEcCtD
Hydromorphone—Arrhythmia—Prednisone—systemic scleroderma	0.000141	0.000477	CcSEcCtD
Hydromorphone—Sweating—Methotrexate—systemic scleroderma	0.000141	0.000476	CcSEcCtD
Hydromorphone—Vomiting—Leflunomide—systemic scleroderma	0.00014	0.000472	CcSEcCtD
Hydromorphone—Hypersensitivity—Lisinopril—systemic scleroderma	0.00014	0.00047	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000139	0.00047	CcSEcCtD
Hydromorphone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000139	0.000469	CcSEcCtD
Hydromorphone—Rash—Leflunomide—systemic scleroderma	0.000139	0.000468	CcSEcCtD
Hydromorphone—Dermatitis—Leflunomide—systemic scleroderma	0.000139	0.000468	CcSEcCtD
Hydromorphone—Mental disorder—Prednisone—systemic scleroderma	0.000139	0.000467	CcSEcCtD
Hydromorphone—Nausea—Azathioprine—systemic scleroderma	0.000139	0.000467	CcSEcCtD
Hydromorphone—Headache—Leflunomide—systemic scleroderma	0.000138	0.000465	CcSEcCtD
Hydromorphone—Malnutrition—Prednisone—systemic scleroderma	0.000138	0.000464	CcSEcCtD
Hydromorphone—Erythema—Prednisone—systemic scleroderma	0.000138	0.000464	CcSEcCtD
Hydromorphone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000461	CcSEcCtD
Hydromorphone—Asthenia—Lisinopril—systemic scleroderma	0.000136	0.000458	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000457	CcSEcCtD
Hydromorphone—Pruritus—Lisinopril—systemic scleroderma	0.000134	0.000452	CcSEcCtD
Hydromorphone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000134	0.000451	CcSEcCtD
Hydromorphone—Rash—Mycophenolic acid—systemic scleroderma	0.000133	0.000447	CcSEcCtD
Hydromorphone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000132	0.000446	CcSEcCtD
Hydromorphone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000444	CcSEcCtD
Hydromorphone—Headache—Mycophenolic acid—systemic scleroderma	0.000132	0.000444	CcSEcCtD
Hydromorphone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000131	0.000442	CcSEcCtD
Hydromorphone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000131	0.000442	CcSEcCtD
Hydromorphone—Nausea—Leflunomide—systemic scleroderma	0.000131	0.000441	CcSEcCtD
Hydromorphone—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000131	0.00044	CcSEcCtD
Hydromorphone—Vision blurred—Prednisone—systemic scleroderma	0.00013	0.000438	CcSEcCtD
Hydromorphone—Urethral disorder—Methotrexate—systemic scleroderma	0.00013	0.000437	CcSEcCtD
Hydromorphone—Diarrhoea—Lisinopril—systemic scleroderma	0.00013	0.000437	CcSEcCtD
Hydromorphone—Ill-defined disorder—Prednisone—systemic scleroderma	0.000128	0.000431	CcSEcCtD
Hydromorphone—Visual impairment—Methotrexate—systemic scleroderma	0.000127	0.00043	CcSEcCtD
Hydromorphone—Agitation—Prednisone—systemic scleroderma	0.000127	0.000427	CcSEcCtD
Hydromorphone—Angioedema—Prednisone—systemic scleroderma	0.000126	0.000424	CcSEcCtD
Hydromorphone—Dizziness—Lisinopril—systemic scleroderma	0.000125	0.000422	CcSEcCtD
Hydromorphone—Nausea—Mycophenolic acid—systemic scleroderma	0.000125	0.000421	CcSEcCtD
Hydromorphone—Malaise—Prednisone—systemic scleroderma	0.000124	0.000419	CcSEcCtD
Hydromorphone—Vertigo—Prednisone—systemic scleroderma	0.000124	0.000417	CcSEcCtD
Hydromorphone—Eye disorder—Methotrexate—systemic scleroderma	0.000124	0.000417	CcSEcCtD
Hydromorphone—Syncope—Prednisone—systemic scleroderma	0.000124	0.000417	CcSEcCtD
Hydromorphone—Tinnitus—Methotrexate—systemic scleroderma	0.000123	0.000416	CcSEcCtD
Hydromorphone—Cardiac disorder—Methotrexate—systemic scleroderma	0.000123	0.000414	CcSEcCtD
Hydromorphone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000412	CcSEcCtD
Hydromorphone—Loss of consciousness—Prednisone—systemic scleroderma	0.000121	0.000408	CcSEcCtD
Hydromorphone—Vomiting—Lisinopril—systemic scleroderma	0.00012	0.000406	CcSEcCtD
Hydromorphone—Angiopathy—Methotrexate—systemic scleroderma	0.00012	0.000405	CcSEcCtD
Hydromorphone—Immune system disorder—Methotrexate—systemic scleroderma	0.000119	0.000403	CcSEcCtD
Hydromorphone—Rash—Lisinopril—systemic scleroderma	0.000119	0.000402	CcSEcCtD
Hydromorphone—Convulsion—Prednisone—systemic scleroderma	0.000119	0.000402	CcSEcCtD
Hydromorphone—Dermatitis—Lisinopril—systemic scleroderma	0.000119	0.000402	CcSEcCtD
Hydromorphone—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000119	0.000402	CcSEcCtD
Hydromorphone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000401	CcSEcCtD
Hydromorphone—Hypertension—Prednisone—systemic scleroderma	0.000119	0.000401	CcSEcCtD
Hydromorphone—Chills—Methotrexate—systemic scleroderma	0.000119	0.0004	CcSEcCtD
Hydromorphone—Headache—Lisinopril—systemic scleroderma	0.000119	0.0004	CcSEcCtD
Hydromorphone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000396	CcSEcCtD
Hydromorphone—Arthralgia—Prednisone—systemic scleroderma	0.000117	0.000395	CcSEcCtD
Hydromorphone—Myalgia—Prednisone—systemic scleroderma	0.000117	0.000395	CcSEcCtD
Hydromorphone—Anxiety—Prednisone—systemic scleroderma	0.000117	0.000394	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000116	0.000393	CcSEcCtD
Hydromorphone—Discomfort—Prednisone—systemic scleroderma	0.000116	0.000391	CcSEcCtD
Hydromorphone—Mental disorder—Methotrexate—systemic scleroderma	0.000116	0.000391	CcSEcCtD
Hydromorphone—Erythema—Methotrexate—systemic scleroderma	0.000115	0.000388	CcSEcCtD
Hydromorphone—Malnutrition—Methotrexate—systemic scleroderma	0.000115	0.000388	CcSEcCtD
Hydromorphone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000383	CcSEcCtD
Hydromorphone—Dysgeusia—Methotrexate—systemic scleroderma	0.000113	0.00038	CcSEcCtD
Hydromorphone—Nausea—Lisinopril—systemic scleroderma	0.000112	0.000379	CcSEcCtD
Hydromorphone—Anaphylactic shock—Prednisone—systemic scleroderma	0.000112	0.000379	CcSEcCtD
Hydromorphone—Infection—Prednisone—systemic scleroderma	0.000112	0.000377	CcSEcCtD
Hydromorphone—Back pain—Methotrexate—systemic scleroderma	0.000111	0.000375	CcSEcCtD
Hydromorphone—Shock—Prednisone—systemic scleroderma	0.000111	0.000373	CcSEcCtD
Hydromorphone—Nervous system disorder—Prednisone—systemic scleroderma	0.00011	0.000372	CcSEcCtD
Hydromorphone—Tachycardia—Prednisone—systemic scleroderma	0.00011	0.00037	CcSEcCtD
Hydromorphone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00011	0.00037	CcSEcCtD
Hydromorphone—Skin disorder—Prednisone—systemic scleroderma	0.000109	0.000368	CcSEcCtD
Hydromorphone—Hyperhidrosis—Prednisone—systemic scleroderma	0.000109	0.000366	CcSEcCtD
Hydromorphone—Vision blurred—Methotrexate—systemic scleroderma	0.000109	0.000366	CcSEcCtD
Hydromorphone—Anorexia—Prednisone—systemic scleroderma	0.000107	0.000361	CcSEcCtD
Hydromorphone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000107	0.00036	CcSEcCtD
Hydromorphone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000356	CcSEcCtD
Hydromorphone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000353	CcSEcCtD
Hydromorphone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000352	CcSEcCtD
Hydromorphone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000104	0.00035	CcSEcCtD
Hydromorphone—Malaise—Methotrexate—systemic scleroderma	0.000104	0.00035	CcSEcCtD
Hydromorphone—Vertigo—Methotrexate—systemic scleroderma	0.000103	0.000349	CcSEcCtD
Hydromorphone—Leukopenia—Methotrexate—systemic scleroderma	0.000103	0.000347	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000102	0.000345	CcSEcCtD
Hydromorphone—Insomnia—Prednisone—systemic scleroderma	0.000102	0.000343	CcSEcCtD
Hydromorphone—Paraesthesia—Prednisone—systemic scleroderma	0.000101	0.00034	CcSEcCtD
Hydromorphone—Cough—Methotrexate—systemic scleroderma	0.0001	0.000339	CcSEcCtD
Hydromorphone—Convulsion—Methotrexate—systemic scleroderma	9.98e-05	0.000336	CcSEcCtD
Hydromorphone—Dyspepsia—Prednisone—systemic scleroderma	9.9e-05	0.000334	CcSEcCtD
Hydromorphone—Nausea—Mycophenolate mofetil—systemic scleroderma	9.85e-05	0.000332	CcSEcCtD
Hydromorphone—Myalgia—Methotrexate—systemic scleroderma	9.8e-05	0.00033	CcSEcCtD
Hydromorphone—Chest pain—Methotrexate—systemic scleroderma	9.8e-05	0.00033	CcSEcCtD
Hydromorphone—Arthralgia—Methotrexate—systemic scleroderma	9.8e-05	0.00033	CcSEcCtD
Hydromorphone—Decreased appetite—Prednisone—systemic scleroderma	9.78e-05	0.00033	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	9.74e-05	0.000328	CcSEcCtD
Hydromorphone—Fatigue—Prednisone—systemic scleroderma	9.7e-05	0.000327	CcSEcCtD
Hydromorphone—Discomfort—Methotrexate—systemic scleroderma	9.69e-05	0.000326	CcSEcCtD
Hydromorphone—Constipation—Prednisone—systemic scleroderma	9.62e-05	0.000324	CcSEcCtD
Hydromorphone—Confusional state—Methotrexate—systemic scleroderma	9.48e-05	0.000319	CcSEcCtD
Hydromorphone—Anaphylactic shock—Methotrexate—systemic scleroderma	9.4e-05	0.000317	CcSEcCtD
Hydromorphone—Infection—Methotrexate—systemic scleroderma	9.34e-05	0.000315	CcSEcCtD
Hydromorphone—Feeling abnormal—Prednisone—systemic scleroderma	9.27e-05	0.000312	CcSEcCtD
Hydromorphone—Nervous system disorder—Methotrexate—systemic scleroderma	9.22e-05	0.000311	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Prednisone—systemic scleroderma	9.2e-05	0.00031	CcSEcCtD
Hydromorphone—Skin disorder—Methotrexate—systemic scleroderma	9.13e-05	0.000308	CcSEcCtD
Hydromorphone—Hyperhidrosis—Methotrexate—systemic scleroderma	9.09e-05	0.000306	CcSEcCtD
Hydromorphone—Anorexia—Methotrexate—systemic scleroderma	8.96e-05	0.000302	CcSEcCtD
Hydromorphone—Urticaria—Prednisone—systemic scleroderma	8.93e-05	0.000301	CcSEcCtD
Hydromorphone—Abdominal pain—Prednisone—systemic scleroderma	8.89e-05	0.0003	CcSEcCtD
Hydromorphone—Body temperature increased—Prednisone—systemic scleroderma	8.89e-05	0.0003	CcSEcCtD
Hydromorphone—Hypotension—Methotrexate—systemic scleroderma	8.78e-05	0.000296	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	8.56e-05	0.000289	CcSEcCtD
Hydromorphone—Insomnia—Methotrexate—systemic scleroderma	8.5e-05	0.000287	CcSEcCtD
Hydromorphone—Paraesthesia—Methotrexate—systemic scleroderma	8.44e-05	0.000284	CcSEcCtD
Hydromorphone—Dyspnoea—Methotrexate—systemic scleroderma	8.38e-05	0.000282	CcSEcCtD
Hydromorphone—Somnolence—Methotrexate—systemic scleroderma	8.35e-05	0.000282	CcSEcCtD
Hydromorphone—Hypersensitivity—Prednisone—systemic scleroderma	8.29e-05	0.000279	CcSEcCtD
Hydromorphone—Dyspepsia—Methotrexate—systemic scleroderma	8.27e-05	0.000279	CcSEcCtD
Hydromorphone—Decreased appetite—Methotrexate—systemic scleroderma	8.17e-05	0.000275	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	8.11e-05	0.000273	CcSEcCtD
Hydromorphone—Fatigue—Methotrexate—systemic scleroderma	8.1e-05	0.000273	CcSEcCtD
Hydromorphone—Asthenia—Prednisone—systemic scleroderma	8.07e-05	0.000272	CcSEcCtD
Hydromorphone—Pain—Methotrexate—systemic scleroderma	8.04e-05	0.000271	CcSEcCtD
Hydromorphone—Pruritus—Prednisone—systemic scleroderma	7.96e-05	0.000268	CcSEcCtD
Hydromorphone—Feeling abnormal—Methotrexate—systemic scleroderma	7.74e-05	0.000261	CcSEcCtD
Hydromorphone—Diarrhoea—Prednisone—systemic scleroderma	7.69e-05	0.000259	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.68e-05	0.000259	CcSEcCtD
Hydromorphone—Urticaria—Methotrexate—systemic scleroderma	7.47e-05	0.000252	CcSEcCtD
Hydromorphone—Dizziness—Prednisone—systemic scleroderma	7.44e-05	0.000251	CcSEcCtD
Hydromorphone—Body temperature increased—Methotrexate—systemic scleroderma	7.43e-05	0.00025	CcSEcCtD
Hydromorphone—Abdominal pain—Methotrexate—systemic scleroderma	7.43e-05	0.00025	CcSEcCtD
Hydromorphone—Vomiting—Prednisone—systemic scleroderma	7.15e-05	0.000241	CcSEcCtD
Hydromorphone—Rash—Prednisone—systemic scleroderma	7.09e-05	0.000239	CcSEcCtD
Hydromorphone—Dermatitis—Prednisone—systemic scleroderma	7.08e-05	0.000239	CcSEcCtD
Hydromorphone—Headache—Prednisone—systemic scleroderma	7.04e-05	0.000237	CcSEcCtD
Hydromorphone—Hypersensitivity—Methotrexate—systemic scleroderma	6.92e-05	0.000233	CcSEcCtD
Hydromorphone—Asthenia—Methotrexate—systemic scleroderma	6.74e-05	0.000227	CcSEcCtD
Hydromorphone—Nausea—Prednisone—systemic scleroderma	6.68e-05	0.000225	CcSEcCtD
Hydromorphone—Pruritus—Methotrexate—systemic scleroderma	6.65e-05	0.000224	CcSEcCtD
Hydromorphone—Diarrhoea—Methotrexate—systemic scleroderma	6.43e-05	0.000217	CcSEcCtD
Hydromorphone—Dizziness—Methotrexate—systemic scleroderma	6.21e-05	0.000209	CcSEcCtD
Hydromorphone—Vomiting—Methotrexate—systemic scleroderma	5.98e-05	0.000201	CcSEcCtD
Hydromorphone—Rash—Methotrexate—systemic scleroderma	5.93e-05	0.0002	CcSEcCtD
Hydromorphone—Dermatitis—Methotrexate—systemic scleroderma	5.92e-05	0.0002	CcSEcCtD
Hydromorphone—Headache—Methotrexate—systemic scleroderma	5.89e-05	0.000198	CcSEcCtD
Hydromorphone—Nausea—Methotrexate—systemic scleroderma	5.58e-05	0.000188	CcSEcCtD
